
The company — based in Dublin, Ireland, and Munich, Germany — describes Verafeye as a novel catheter-based imaging system that provides real-time, two and four-dimensional, 360-degree visualization, enhancing clinician precision and confidence during complex electrophysiology and structural heart procedures.
Luma Vision says it has prepared the system for magnetic tracking and navigation of third-party catheters. Other Verafeye features include imaging depths up to 120 mm away from the catheter and dynamic high-resolution navigation and visualization of the heart.
“Our clinical experience with Verafye is exciting, with the potential to simplify procedural workflow and efficiency,” Dr. Shephal Doshi, director of electrophysiology at Pacific Heart Institute/Cedars Sinai and investigator of the Verafeye system, said in a news release. “Real-time visualization and rapid creation of cardiac anatomy can facilitate de novo procedures with greater simplicity.”
Dr. Anish Amin, system medical chief for cardiac electrophysiology at OhioHealth Heart and Vascular, described Verafeye as a major advancement in intraprocedural cardiac imaging. “Verafeye’s imaging capabilities demonstrate a necessary path forward in precision imaging and a strong foundation to further advance the standard of care.”